353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study
| Autor: | Masuda, N., Ohtani, S., Nagai, S., Takashima, S., Yamaguchi, M., Tsuneizumi, M., Komoike, Y., Osako, T., Ito, Y., Ikeda, M., Ishida, K., Nakayama, T., Takashima, T., Asakawa, T., Matsumoto, S., Shimizu, D., Takahashi, M. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v127-v128 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|